Petal has raised $277.0M in total across 6 funding rounds.
Petal's investors include Abstract Ventures, Afore Capital, Cherry Ventures, Core Innnovation Capital, EQT Ventures, Felicis Ventures, FinTech Collective, Golden Ventures, Graph Ventures, Great Oaks Venture Capital, Ground Up Ventures, GSV Acceleration.
Petal refers to multiple technology companies, but the most prominent in healthcare is the Canadian firm founded in 2010 in Quebec City, specializing in digital platforms for real-time care orchestration and medical billing.[1][2] It serves healthcare organizations, including physicians, managers, and administrators, by optimizing operations through tools like patient appointment portals, clinical capacity management, care coordination, physician scheduling, and secure cloud-based communication.[1] The company addresses key challenges such as aging populations, obsolete systems, limited staff, and resource constraints by enabling interoperability of existing systems, improving access to care, and matching patient demand with delivery—demonstrating strong growth with 384% revenue increase from 2018-2021 and recognition as one of Canada's Top Growing Companies in 2022 (ranked 122nd out of 430).[2] With nearly 300-375 employees, it operates in Canada, France, Switzerland, Belgium, and the US.[1][2]
(Note: Other entities include a US fintech Petal offering credit cards via cash-flow underwriting, now part of Tilt;[3][5] a neurotech software firm in Austin;[4][7] and an academic productivity tool.[6] This overview prioritizes the healthcare leader based on detailed, consistent sources.)
Petal (healthcare) was founded in 2010 in Quebec City, Canada, by healthcare technology enthusiasts aiming to tackle systemic inefficiencies in healthcare delivery.[1][2] Emerging from a need to empower innovators amid challenges like staff shortages and outdated infrastructure, the company built an "orchestration platform" that integrates and adapts existing systems for faster innovation deployment.[2] Early traction came from focusing on Quebec's healthcare network, enabling real-time decision-making for care matching; by 2022, this propelled 384% three-year revenue growth and national recognition.[2] The team's agile, startup-like culture—balancing autonomy, expert collaboration, and social events—fueled expansion to international markets.[1]
Petal rides the digital health orchestration trend, addressing global healthcare strains from aging demographics and resource limits through AI-driven efficiency and interoperability—critical as systems lag behind patient needs.[1][2] Timing aligns with post-pandemic demands for scalable access, where Canada's public system challenges mirror worldwide issues, positioning Petal to influence ecosystems via exports to Europe and the US.[2] Market forces like tech adoption in legacy healthcare favor its non-disruptive model, which builds on incumbents rather than replacing them, fostering broader innovation in care delivery and outcomes.[1][2]
Petal's healthcare focus positions it for sustained expansion amid rising demand for efficient, interoperable platforms, potentially deepening US/European penetration and integrating AI for predictive orchestration.[1][2] Trends like value-based care and telehealth will amplify its impact, evolving it from Quebec innovator to global leader—echoing its origin as a bold response to systemic challenges, now scaling to transform health outcomes at population levels.[1][2]
Petal has raised $277.0M across 6 funding rounds. Most recently, it raised $35.0M Venture Round in May 2023.
